Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Declines By 5.2%
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 16,230,000 shares, a drop of 5.2 ...
Neuren secures FDA Fast Track designation for NNZ-2591 in Pitt Hopkins syndrome
Neuren Pharmaceuticals (ASX: NEU) has announced that the US Food and Drug Administration (FDA) has granted Fast Track ...
STAT20h
Biogen partners with Stoke Therapeutics on drug for severe epilepsy
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, ...
Unlocking Huntington's Disease: DNA Repair Protein Could Hold Key To New Treatments
A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...
Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments
Innate Pharma SA (IPHA) announced that the FDA has granted Breakthrough Therapy Designation to lacutamab for treating adults ...